Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer
Clinical trial NCT04133155 · COMPLETED
Trial details
- NCT number
- NCT04133155
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-16
- Primary completion
- 2020-01-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.